Skip to main content
FOR BIOTECH TEAMS

Make your asset stand out to pharma

Reserve your spot on Prudentia. Build a diligence-ready profile, evaluate your asset, and connect with verified pharma BD teams, free to join.

Reserve your spotReserve your spot
  • SOC II aligned
Biotech researcher in blue gloves retrieving reagents from a laboratory refrigerator
THE INFORMATION GAP

Identify your blindspots before you meet with partners

Most biotech teams have done only a handful of deals. Buyers and investors have seen thousands. Prudentia helps you identify blind spots early and shape how your asset is evaluated, long before engagement begins.

Without Prudentia

"We found out about the CMC data gap in the middle of diligence."

WithPrudentia

“We saw the risk early and addressed it before it became an issue.”

Without Prudentia

“Our asset is worth more than they’re offering.”

WithPrudentia

"We came in with data behind our number. The offer landed where it should."

Without Prudentia

“Why is it so hard to get to the deal-table with Pharma?”

WithPrudentia

"We got to the table. Pharma already knew what we had."

HOW PRUDENTIA WORKS

A secure deal-ready workspace for your asset

Position your asset for success by understanding potential risks, valuations, competitive positioning, and connecting to the right partners at the right time.

Prepare your asset for diligence

01 •Consolidate materials from VDRs, internal tools, and external sources into one system
02 •Evaluate your asset against structured frameworks tailored to your biology, modality, and stage
03 •Model risk-adjusted NPV and benchmark against comparable, mechanism-matched deals
Diligence-readiness interface showing an asset score rising from 62 to 76 with recommended actions

Monitor your competitive landscape

01 •Search and compare programs by indication, target, and modality
02 •Track new data, regulatory signals, and deal activity as they emerge
03 •See how your asset compares in real time
Competitive landscape view comparing assets across pipelines and emerging programs

Connect with the right partners

01 •Set your criteria and surface matched pharma companies and investors
02 •Selectively expose your profile to interested parties on your terms
03 •Manage inbound interest from one place
Partner-matching interface ranking pharma companies by fit score against an asset
EARLY ACCESS

Get your asset in front of verified partners

Set up your asset profile in minutes using your existing materials. No confidential information required.

Reserve your spot
01Share links

Prudentia scans your website and LinkedIn to pre-populate your profile.

02Confirm

Review and confirm basic information about your company and assets.

03Objectives

Tell us what you're working toward: out-licensing, raising capital, M&A, or something else.

04Upload

Your corporate or non-confidential deck. Nothing proprietary needed.

05You’re in

Prudentia confirms your spot and will reach out before launch.

1 of 5
Scientist standing in a laboratory holding a tablet, with glassware and reagents on the shelves behind
UNDER DILIGENCE?

Is your asset being evaluated through Prudentia?

  • Your data is isolated and never shared across customers or used to train models.
  • You control access and can revoke it at any time, with a complete audit trail.
  • Every handoff between pharma, your VDR, and Prudentia is disclosed. Each party's role is bounded.
  • Pharma reaches conviction faster. You spend less time in limbo.
SECURITY

Protected by design

Life sciences dealmaking involves some of the most sensitive data in the industry.

Visit our Trust CenterVisit our Trust Center
  • SOC II aligned
  • AWS-hosted

Secure Private Infrastructure

Single-tenant deployment with your data siloed and never shared across customers

Granular access controls

SSO integration with granular access controls and permissions

Data protected end-to-end

Encryption at rest and in transit, with complete audit trails

Built-in compliance

Your data is never used to train models, aligned with ISO/IEC 42001:2023